Appendix for the 1st Quarter of 41th
business period(Fiscal Year Ending March 31, 2025)

July 31, 2024
TECHMATRIX CORPORATION（code：3762）

Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

1. Business Highlights for the 1st Quarterbusiness period (Consolidated)

1
Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Business Highlights for FY2024 1Q (Consolidated)• The highest for 1Q consolidated revenue, operating profit, profit before tax
and profit attributable to owners of parent.
（¥million）

FY20241Q

FY2023
1Q
Revenue

YoY
ChangeChange%+20.0%+24.0%+0.3P

Operating profit
Profit ratio

11,473898
7.8%

13,7631,113
8.1%+2,289+215

Profit before tax

910

1,130+220+24.2%

Profit attributable toowners of parent

560

726

+165

+29.6%
2

Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Business Highlights for FY2024 1Q (Consolidated)（¥million）

FY2023 1Q

Revenue
Information
Infrastructure
Application
Service
Medical System
Operating profit
Information
Infrastructure
Application
Service
Medical System

Profitratio％

Results

FY2024 1Q
Results

YoY
Profitratio%changeChange%11,473100.0%13,763

100.0%+2,289+20.0%

7,478

65.2%

9,606

69.8%

+2,128+28.5%

1,883

16.4%

2,102

15.3%

+219

+11.6%

2,112

18.4%

2,054

14.9%

△57

△2.7%

898

100.0%

7.8%

1,113

100.0%

8.1%+215+24.0%

646

72.0%

8.7%

940

84.5%

9.8%

+293

+45.4%

34

3.8%

1.8%

63

5.7%

3.0%

+29+85.8%

216

24.1%

10.3%

109

9.8%

5.3%

△107

△49.7%
3

Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Business Highlights for FY2024 1Q (Consolidated)
Information Infrastructure Business: Demand for cloud-based security products drove overall performance.
Application Service Business: Progress in the shift to stock business contributed to performance, with double-digit revenue growth
YoY in the CRM, SE, BS, and EdTech fields.
Medical Systems Business: For business expansion, Personnel expenses and aggressive development investments increased.

Revenue（¥million）

Operating profit（¥million）+2,28920.0% ↑+215
24.0% ↑Revenue breakdown

Operating profit breakdown

15%
15%

FY2024
1Q¥13.76bn

Information Infrastructure
Application Service70%

Medical System

10%6%FY2023¥1.11bnInformation Infrastructure
Application Service
Medical System

84%

4Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Business Highlights for FY2024 1Q by Segment (Consolidated)
Information Infrastructure BusinessRevenue（¥million）+2,128
28.5% ↑The highest for 1Q consolidated revenue and Operating profit.
•Revenue(+) Increasing demands for cloud-based security products(subscriptionbased).
(+) Strong demand for Next-generation anti-virus products utilizing AI.
(+) Strong demand for Next-Generation Mail security solutions.
(+) Accumulation of multi-year subscriptions.

Operating profit•（¥million）+293

Operating profit(+) SG&A expenses less increased compared to Revenue growth.
(+) Operating Profit of CROSS HEAD improved YoY.
(+) Thoroughly conducted sales activities with profitability in mind.

45.4% ↑5Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Business Highlights for FY2024 1Q by Segment (Consolidated)
Application Service BusinessRevenue（¥million）+219
11.6% ↑Operating profit（¥million）

Revenue and Operating profit increased YoY.
••Revenue(+) Demands on quality testing tools for enterprise systems andembedded software were strong. （SE）(+) In the CRM field and Software Quality Assurance field, revenue andoperating profit increased due to the accumulation of stock-typebusinesses accelerated by the progress of subscriptions.
（CRM, SE）(+) Increased revenue due to the increase of number of schools
using ″tsumugino". （EdTech）

Operating profit(−) Increased in labor and SG&A expenses due to business expansion.
(−) Increased amortization expenses due to the previous year's
strategic investments on products development. （EdTech）+29
85.8% ↑※ Division name abbreviation
CRM: Contact center / Call center
SE: Software quality assurance
BS: Business solution
EdTech: Education

6Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Business Highlights for FY2024 1Q by Segment (Consolidated)
Medical System BusinessRevenue（¥million）△57△2.74% ↓Operating profit（¥million）

Revenue and Operating profit decreased YoY.
••

Revenue(+) The medical imaging system (PACS) is steady.
(+) NOBORI, a medical information cloud service and a PHR application,performed well.
(−) On-premise projects in 1Q were delayed.
(−) Gradual shift to cloud computing

Operating profit(+) Special factors such as costs related to unification of treatment
systems have been eliminated. （¥98million）(−) Increased in SG&A expenses due to increase in number ofemployees.
(−) Increased in SG&A expenses due to aggressive development
investment.

△107
49.7% ↓7Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Booking and Backlog for FY2024 1Q (Consolidated)• Booking was strong compared to the last fiscal year.
• Strong backlogs, in particular, in Information Infrastructure business.
• Market conditions were favorable for all Information Infrastructure, Application Service, and Medical System businesses.
Bookings steadily increased.

Booking（¥million）

Company-wide totalBacklog（¥million）+6,818+20,685

45.9% ↑

37.1% ↑Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

8

Booking by Segment for FY2024 1Q (Consolidated)• Information Infrastructure Business： Increased demands for cloud-based security products (new / renewal).
• Application Service Business： All segments performed well, especially in the Software quality assurance field.
• Medical System Business： Bookings for medical image management systems (PACS) were steady and exceeded the plan.
Information Infrastructure Business（¥million）

Application Services Business

Medical System Business（¥million）（¥million）+6,349△294△9.7% ↓+63.9% ↑+762
40.6% ↑※ Division name abbreviation
CRM: Contact center / Call center, SE: Software quality assurance, BS: Business solution, EdTech: Education
Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

9

Booking for FY2024 1Q by Field (Consolidated)

Application Service Business（¥million）

900＋124(17.8%↑)800700

FY2023 1Q＋462(46.5%↑)

FY2024 1Q＋7(1.1%↑)

600500826400

777

701637 644

300＋154(705.6%↑)

200+34(20.9%↑)3152011001760CRMSEBS21Edtech

166
CASAREAL△21(17.6%↓)
122 101
ARECCIA Fintech※ Figures before consolidation adjustments between divisions※ Division name abbreviation
CRM: Contact center / Call center, SE: Software quality assurance, BS: Business solution, EdTech: Education
Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

10

Backlog by Segment for FY2024 1Q (Consolidated)• In increasing tendency due to shift to subscription (strengthening stock business).
Information Infrastructure
Business（¥million）

Medical System Business

Application Services Business（¥million）（¥million）+2,404+16,868

20.6% ↑
42.5% ↑+1,412
31.7% ↑

11Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Backlog for FY2024 1Q (Non-Consolidated)• Consolidated and non-consolidated (TechMatrix only) backlogs are as follows.
Backlog(Consolidated)

Backlog(Non-consoliated)

80.7% ofconsolidated
backlog（¥million）（¥million）

About+20,685+17,546

37.1% ↑

39.7% ↑

12
Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Backlog for FY2024 1Q (Non-Consolidated)• Non-consolidated backlog (for only TechMatrix) are as follows.
Short term
系列1（¥million）

70,00060,000※Short term
Backlog (in each quarter) whose revenue will be recognized within a year
※long term
Backlog (in each quarter) whose revenue will be recognized after one year

50,00040,000

45.7%

46.1%

46.6%

44.6%

46.9%

30,00020,00010,0000long term rate
系列3Long term
系列2

47.9%

18,393
11,98814,247
FY2021Q1

13,38915,632
FY2021
Q2

14,09016,130
FY2021
Q3

13,50016,737
FY2021Q4

47.8%

18,75554,995

47.6%

19,701

49.2%

49.3%

52.1%80.0%
61,744
51.5%

52.8%

60.0%
31,786

21,747

21,932

26,54129,01540.0%

16,091

18,236FY2022
Q120,018

FY2022
Q220,444

FY2022
Q321,702

FY2022
Q422,451

FY2023
Q122,579

FY2023
Q224,388

FY2023
Q325,980

FY2023
Q429,958

FY2024
Q120.0%0.0%

13
Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

ARRR for FY2024 1Q (Non-Consolidated)• Non-consolidated ARRR (only at TechMatrix) is as follows.
（¥million）

40,000

ARRR
系列1YoY ＋22.7％※ARRR（Annual Revenue Run Rate）
Projected revenue on a yearly basis, converted based on each quarter’srecurring revenue(4x)20,000019,185

19,863

20,38322,06016,337

17,809FY2021Q1

FY2021Q2

FY2021Q3

FY2021Q4

FY2022Q1

FY2022
Q223,996

25,553

27,216

28,779FY2022Q3

FY2022Q4FY2023Q1

FY2023
Q230,342

31,69233,407

FY2023Q3

FY2023Q4

FY2024Q1

14
Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Stock type sales (Recurring revenue) ratio of TECHMATRIX and PSP
Information Infrastructure
Business（¥million）

77.4%

84.2%

70.0%
60.0%

5,550

50.0%
40.0%

15,00010,00024,612
19,016

30.0%
1,323

5,000
0

90.0%
80.0%

5,302

25,00020,000

82.3%

7,025
FY2022

FY2023 FY2024 1Q

Stock
Non-Stock
Stock ratio

20.0%
10.0%
0.0%

14,00012,000

62.4%

65.6%

70.2%

80.0%

14,00070.0%

12,00060.0%

10,000

50.0%

8,000

40.0%
6,000

2,386

2,438

0

20.0%
3,962

FY2022

4,643

10,000

70.0%

65.3%
49.1%

8,000
6,000

4,575

60.0%

49.9%

50.0%
40.0%

4,871

30.0%

30.0%

4,000
2,000

Medical System Business（¥million）（¥million）

35,00030,000Application Services Business

531
1,249

FY2023 FY2024 1Q

10.0%
0.0%

Stock
Non-Stock
Stock ratio※ FY2024 1Q excludes financial business
Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

20.0%

4,000
2,000
0

4,416

4,855

679
1,277

FY2022

FY2023

FY2024 1Q

10.0%
0.0%

Stock
Non-Stock
Stock ratio

15

2. Forecast for Fiscal Year ending March31, 2025
(Targets in the next 3 years)

16
Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Creating Customer Value in the New Era Targets in the next 3 years
Operatingincome
10Billion yen
Creating Customer Value in the New Era （FY2024～FY2026）（Plan）Net sales：750million yen
Operating income：82million yen

BEYOND THE NEW NORMAL（FY2021～FY2023）

Net sales：533million yen
Operating income：58.5million yen

GO BEYOND3.0（FY2018～FY2020）

Net sales：30９million yen
Operating income：3５．８million yen

・ Established New PSP Corporation（Acquired shares of PSP Corporation and integrated business with NOBORI Ltd.）・Established 「M3 AI, Inc.」 together with M3, Inc. and PSP.
・Capital and business alliance with Educa & Quest Inc.
・Established local subsidiary TechMatrix Asia in Thailand
・Business and capital alliance with Mobilus Corporation

・communication platform ＋Integrated school affairs support system「tsumugino」 service started・Started providing PHR services for individuals (patients)

・Established NOBORI Ltd.
Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

17

Creating Customer Value in the New Era Targets in the next 3 years（Summary）(100million yen)

FY2026
PlanFY2023
ActualNetsales

Total533.0

750.0

140.7％

Informationinfrastructure

350.0

523.5

149.6%

Application
service

82.0

115.5

140.9%

Medical System

101.0

111.0

109.9%

Total

58.5

82.0

140.2％

Information
infrastructure

39.7

54.8

138.0%

Application
service

3.2

13.5

421.9%

Medical System

15.6

13.7

８7．8%

(100million yen)

OperatingincomeCopyright (c) 2024 TechMatrix Corporation. All rights reserved.

18

Creating Customer Value in the New Era 3-year targets （Consolidated）
Net sales(million yen)

Operating
IncomeOperatingincome margin

80,00020.0%

75,00066,00059,00060,00015.0%53,30312.0%
40,000

10.6%

9.5%

0FY2018

11.1%

5,098

30,603

3,686
2,419

45,95036,51328,55325,41820,000

10.2%

8,200
6,500
5,850

11.0%

11.0%

8,000

7,000
10.6%

10.9%

3,734

10.0%
6,000
4,000

3,028

5.0%
2,000

FY2019FY2020

FY2021

FY2022

FY2023Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

FY2024FY2025

FY20260.0%

19

Creating Customer Value in the New Era 3-year targets （Information infrastructure）
Net sales(million yen)

Operating
IncomeOperatingincome margin

60,00020.0%

・Plans to proactively invest to strengthen
support personnel
・Considering uncertain exchange rate trends

52,35045,60040,00040,000

13.1%

12.4%

12.0%

24,711
19,006

16,95820,997

2,761

3,054

5,480

35,006

10.7%

11.4%

29,305

10.5%
20,000

6,000
15.0%

3,973

3,125

4,440
11.1%

4,800
10.5%

10.5%

2,280
2,000
5.0%

1,778

0

FY2018

10.0%
4,000

FY2019FY2020

FY2021

FY2022

FY2023Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

FY2024FY2025

FY20260.0%

20Creating Customer Value in the New Era 3-year targets （Application service）(million yen)

Net sales

14,000Operating
IncomeOperatingincome margin

・Progress in transition to subscription-based business・EdTech business deficit shrinks
30.0%＊Application services and Medical systemseparated from FY2022.
（After PSP merger）

11,55011,000

10,200
9,200

8,000

7,300

10.8%

20.0%

8,205

1,100
6.6%

5,000

3.9%

-1,00011.7%

610△21FY2022

FY2023

1,000

10.0%
500

317

2,000

1,500

1,350

FY2024FY2025

Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

FY20260.0%

21Creating Customer Value in the New Era 3-year targets （Medical System）Net sales(million yen)

12,000

FY2024-FY2025 is investment phase to increase sales andprofits from FY2026 onwards.

Operatingincome margin

30.0%＊Application services and Medical systemseparated from FY2022.
（After PSP merger）

9,344
8,000

Operating
Income21.3%

11,10010,092

10,200

9,800

20.0%
1,993

1,560

2,000

14.8%

15.5%

10.8%
1,450

1,370
10.0%
1,000

1,100

4,000

012.3%FY2022

FY2023

FY2024FY2025

Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

FY20260.0%

22Creating Customer Value in the New Era 3-year targets （Medical System）
FY2024-FY2025 is investment phase to increase sales and profits from FY2026 onwards.

１) Cloud shift of PACS business☞This will result in a short-term decrease insales and operating income.
However, this is a management decision
with an eye to the future.

Pathology

CloudPACS
PHR

Overseas
expansion２) Increase in staff for business expansionAI３) Aggressive development investment

Datautilization

Copyright (c) 2024 TechMatrix Corporation. All rights reserved.

Remoteimagingdiagnosis

Medicalexposure
dose23

＜Handling of this material＞
Description of future prospect contained in this material, etc. is based on current information.
It may fluctuate due to Macroeconomic trends, Market environment, Our related industry trends, Other internal ・ external
factors, etc.
Therefore, there are risks and certainty that actual performance may differ from the descriptions of future prospect, etc.
＜Contact＞
TECHMATRIX CORPORATION Corporate Planning Department

ir@techmatrix.co.jp

Copyright (c) 2024 TechMatrix Corporation. All rights reserved.